See more : Yandex N.V. (YNDX) Income Statement Analysis – Financial Results
Complete financial analysis of DaVita Inc. (DVA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DaVita Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- PT Data Sinergitama Jaya Tbk (ELIT.JK) Income Statement Analysis – Financial Results
- Keywords Studios plc (KWS.L) Income Statement Analysis – Financial Results
- SAG Holdings Ltd (SAG) Income Statement Analysis – Financial Results
- XD Inc. (2400.HK) Income Statement Analysis – Financial Results
- Paymentus Holdings, Inc. (PAY) Income Statement Analysis – Financial Results
DaVita Inc. (DVA)
About DaVita Inc.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.14B | 11.61B | 11.62B | 11.55B | 11.39B | 11.40B | 10.88B | 14.75B | 13.78B | 12.80B | 11.76B | 8.19B | 6.79B | 6.45B | 6.11B | 5.66B | 5.26B | 4.88B | 2.97B | 2.30B | 2.05B | 1.85B | 1.65B | 1.49B | 1.45B | 1.20B | 438.20M | 272.90M | 89.70M | 99.00M |
| Cost of Revenue | 8.32B | 8.21B | 7.97B | 7.99B | 7.91B | 8.20B | 7.64B | 10.65B | 9.82B | 9.12B | 8.20B | 5.58B | 4.68B | 4.47B | 4.25B | 3.92B | 3.59B | 3.39B | 2.04B | 1.56B | 1.36B | 1.22B | 1.10B | 1.03B | 993.24M | 772.70M | 292.50M | 184.00M | 57.40M | 65.60M |
| Gross Profit | 3.82B | 3.40B | 3.65B | 3.56B | 3.47B | 3.21B | 3.24B | 4.10B | 3.96B | 3.68B | 3.57B | 2.61B | 2.11B | 1.97B | 1.86B | 1.74B | 1.67B | 1.49B | 938.68M | 743.53M | 685.86M | 636.95M | 550.10M | 454.15M | 452.11M | 432.20M | 145.70M | 88.90M | 32.30M | 33.40M |
| Gross Profit Ratio | 31.47% | 29.29% | 31.38% | 30.84% | 30.50% | 28.14% | 29.76% | 27.79% | 28.71% | 28.73% | 30.31% | 31.85% | 31.08% | 30.60% | 30.45% | 30.74% | 31.80% | 30.54% | 31.56% | 32.35% | 33.52% | 34.34% | 33.32% | 30.56% | 31.28% | 35.87% | 33.25% | 32.58% | 36.01% | 33.74% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.47B | 1.36B | 1.20B | 1.25B | 1.10B | 1.14B | 1.06B | 1.59B | 1.45B | 1.26B | 1.18B | 894.58M | 691.24M | 579.00M | 531.53M | 654.47M | 627.92M | 579.72M | 334.38M | 233.04M | 195.33M | 181.33M | 126.90M | 163.27M | 263.81M | 120.20M | 38.70M | 24.80M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.47B | 1.36B | 1.20B | 1.25B | 1.10B | 1.14B | 1.06B | 1.59B | 1.45B | 1.26B | 1.18B | 894.58M | 691.24M | 579.00M | 531.53M | 654.47M | 627.92M | 579.72M | 334.38M | 233.04M | 195.33M | 181.33M | 126.90M | 163.27M | 263.81M | 120.20M | 38.70M | 24.80M | 9.40M | 11.50M |
| Other Expenses | 743.66M | 732.60M | 680.62M | 630.44M | 615.15M | 583.74M | 17.67M | 8.73M | 8.89M | 2.37M | 4.79M | 3.74M | 455.42M | 396.63M | 388.33M | 263.45M | 183.68M | 171.16M | 138.93M | 100.36M | 112.00M | 64.29M | 105.21M | 111.61M | 112.48M | 92.00M | 27.10M | 15.40M | 4.40M | 0.00 |
| Operating Expenses | 2.22B | 2.09B | 1.88B | 1.88B | 1.72B | 1.72B | 1.62B | 2.32B | 2.59B | 1.88B | 2.11B | 1.33B | 956.43M | 975.63M | 919.86M | 917.92M | 811.60M | 750.88M | 473.30M | 333.40M | 307.33M | 245.62M | 232.11M | 274.88M | 376.29M | 212.20M | 65.80M | 40.20M | 13.80M | 16.20M |
| Cost & Expenses | 10.54B | 10.30B | 9.85B | 9.87B | 9.63B | 9.91B | 9.26B | 12.97B | 12.42B | 11.00B | 10.31B | 6.91B | 5.64B | 5.45B | 5.17B | 4.84B | 4.40B | 4.14B | 2.51B | 1.89B | 1.67B | 1.46B | 1.33B | 1.31B | 1.37B | 984.90M | 358.30M | 224.20M | 71.20M | 81.80M |
| Interest Income | 0.00 | 368.75M | 279.75M | 297.03M | 435.23M | 0.00 | 0.00 | 0.00 | 0.00 | 17.41M | 0.00 | 288.53M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 398.55M | 357.02M | 285.25M | 304.11M | 443.82M | 487.44M | 430.63M | 414.38M | 405.94M | 410.29M | 429.94M | 0.00 | 241.09M | 255.99M | 185.76M | 199.89M | 156.95M | 489.02M | 107.74M | 44.07M | 113.71M | 98.33M | 71.43M | 149.58M | 399.35M | 256.00M | 15.40M | 14.40M | 4.10M | 0.00 |
| Depreciation & Amortization | 745.44M | 732.60M | 680.62M | 630.44M | 615.15M | 591.04M | 559.91M | 509.50M | 638.02M | 590.94M | 528.12M | 343.91M | 267.32M | 234.38M | 228.99M | 216.92M | 193.47M | 173.30M | 119.72M | 86.67M | 74.69M | 64.67M | 105.21M | 111.61M | 112.48M | 92.00M | 27.10M | 15.40M | 4.40M | 4.70M |
| EBITDA | 2.35B | 2.05B | 2.45B | 2.31B | 2.37B | 2.08B | 2.38B | 2.55B | 1.77B | 2.43B | 2.10B | 1.63B | 1.43B | 1.23B | 1.16B | 1.03B | 1.06B | 912.73M | 465.37M | 467.79M | 434.62M | 448.49M | 416.07M | 290.88M | 188.30M | 303.40M | 165.20M | 105.70M | 33.20M | 21.90M |
| EBITDA Ratio | 19.33% | 17.71% | 21.38% | 20.42% | 21.19% | 18.30% | 22.12% | 17.06% | 14.37% | 18.06% | 17.23% | 19.96% | 20.94% | 19.10% | 19.14% | 18.13% | 18.58% | 23.33% | 19.50% | 21.43% | 23.29% | 24.25% | 25.36% | 20.36% | 22.83% | 31.98% | 23.87% | 22.79% | 24.75% | 22.12% |
| Operating Income | 1.60B | 1.34B | 1.80B | 1.69B | 1.64B | 1.53B | 1.81B | 1.89B | 1.17B | 1.82B | 1.55B | 1.30B | 1.13B | 997.03M | 940.27M | 821.77M | 862.21M | 739.43M | 465.37M | 410.12M | 378.54M | 391.33M | 317.99M | 179.27M | 75.82M | 220.00M | 79.90M | 48.70M | 18.50M | 17.20M |
| Operating Income Ratio | 13.20% | 11.53% | 15.47% | 14.67% | 14.43% | 13.38% | 16.67% | 12.85% | 8.49% | 14.19% | 13.18% | 15.84% | 16.65% | 15.46% | 15.39% | 14.52% | 16.38% | 15.15% | 15.65% | 17.84% | 18.50% | 21.10% | 19.26% | 12.06% | 5.25% | 18.26% | 18.23% | 17.85% | 20.62% | 17.37% |
| Total Other Income/Expenses | -425.69M | -372.78M | -278.88M | -376.37M | -447.88M | -477.35M | -412.97M | -406.61M | -413.63M | -505.47M | -425.16M | -295.78M | -238.11M | -252.57M | -182.05M | -164.97M | -234.69M | -263.67M | -134.27M | -19.24M | -71.67M | -67.64M | -68.29M | -134.34M | -257.65M | -164.40M | 1.30M | 8.70M | -3.60M | -8.80M |
| Income Before Tax | 1.18B | 966.28M | 1.52B | 1.32B | 1.20B | 1.05B | 1.40B | 1.49B | 723.14M | 1.31B | 1.12B | 1.00B | 892.67M | 744.46M | 758.22M | 609.46M | 627.52M | 475.76M | 331.10M | 361.88M | 288.27M | 316.19M | 240.94M | 44.94M | -181.83M | 56.90M | 62.10M | 40.10M | 11.10M | 8.40M |
| Income Before Tax Ratio | 9.70% | 8.32% | 13.07% | 11.41% | 10.50% | 9.19% | 12.87% | 10.10% | 5.25% | 10.24% | 9.56% | 12.23% | 13.14% | 11.55% | 12.41% | 10.77% | 11.92% | 9.75% | 11.13% | 15.74% | 14.09% | 17.05% | 14.60% | 3.02% | -12.58% | 4.72% | 14.17% | 14.69% | 12.37% | 8.48% |
| Income Tax Expense | 220.12M | 198.09M | 306.73M | 313.93M | 279.63M | 258.40M | 323.86M | 455.81M | 295.73M | 446.34M | 381.01M | 359.85M | 315.74M | 260.24M | 278.47M | 235.30M | 245.74M | 186.43M | 123.68M | 139.63M | 112.48M | 129.50M | 104.60M | 27.96M | -34.57M | 41.60M | 25.10M | 16.40M | 4.60M | 3.50M |
| Net Income | 691.54M | 768.19M | 978.45M | 773.64M | 810.98M | 790.08M | 663.62M | 879.87M | 269.73M | 723.11M | 633.45M | 536.02M | 478.00M | 405.68M | 422.68M | 374.16M | 381.78M | 289.69M | 228.64M | 222.25M | 175.79M | 157.33M | 137.32M | 13.49M | -147.26M | -4.30M | 37.00M | 16.00M | 9.10M | 4.90M |
| Net Income Ratio | 5.70% | 6.62% | 8.42% | 6.70% | 7.12% | 6.93% | 6.10% | 5.97% | 1.96% | 5.65% | 5.38% | 6.55% | 7.04% | 6.29% | 6.92% | 6.61% | 7.25% | 5.94% | 7.69% | 9.67% | 8.59% | 8.48% | 8.32% | 0.91% | -10.19% | -0.36% | 8.44% | 5.86% | 10.14% | 4.95% |
| EPS | 7.62 | 8.26 | 9.30 | 6.54 | 5.29 | 4.63 | 3.52 | 4.36 | 1.27 | 3.41 | 3.02 | 2.79 | 2.52 | 2.00 | 2.04 | 1.78 | 1.80 | 1.40 | 1.13 | 1.13 | 0.93 | 0.73 | 0.55 | 0.06 | -0.60 | -0.02 | 0.24 | 0.14 | 0.08 | 0.09 |
| EPS Diluted | 7.42 | 8.02 | 8.90 | 6.39 | 5.27 | 4.58 | 3.47 | 4.29 | 1.25 | 3.33 | 2.95 | 2.74 | 2.48 | 1.97 | 2.03 | 1.77 | 1.78 | 1.37 | 1.10 | 1.08 | 0.77 | 0.58 | 0.49 | 0.05 | -0.60 | -0.02 | 0.24 | 0.13 | 0.08 | 0.08 |
| Weighted Avg Shares Out | 90.79M | 92.99M | 105.23M | 119.80M | 153.18M | 170.79M | 188.63M | 201.64M | 211.87M | 212.30M | 209.94M | 192.04M | 189.32M | 203.01M | 207.21M | 210.30M | 211.79M | 207.04M | 201.52M | 197.45M | 188.69M | 215.49M | 251.30M | 244.74M | 243.46M | 240.43M | 155.05M | 114.73M | 111.48M | 54.42M |
| Weighted Avg Shares Out (Dil) | 93.18M | 95.83M | 109.95M | 122.62M | 153.81M | 172.36M | 191.35M | 204.90M | 216.25M | 216.93M | 214.76M | 195.94M | 193.06M | 206.12M | 208.34M | 211.88M | 214.84M | 211.59M | 208.14M | 205.72M | 227.52M | 271.44M | 278.82M | 249.47M | 243.46M | 245.10M | 155.05M | 119.94M | 111.48M | 61.22M |
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors
DaVita HealthCare (DVA) closed the most recent trading day at $163.08, moving +0.51% from the previous trading session.
Should Value Investors Buy DaVita (DVA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong...
Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?
Here is how DaVita HealthCare (DVA) and Adagene Inc. Sponsored ADR (ADAG) have performed compared to their sector so far this year.
DaVita Stock Rallies 17% in 3 Months: Is it Still Worth Buying?
DVA stock has the potential to continue its uptrend on the back of better revenues per treatment as well as growth of the overall dialysis market.
Are You Looking for a Top Momentum Pick? Why DaVita HealthCare (DVA) is a Great Choice
Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3 Stocks Warren Buffett Owns More Than 10% of Right Now
In August, Warren Buffett's Berkshire Hathaway (NYSE: BRK-B) became the first non-tech U.S.
Here's Why DaVita HealthCare (DVA) Fell More Than Broader Market
DaVita HealthCare (DVA) closed the most recent trading day at $163.16, moving -0.65% from the previous trading session.
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know
In the most recent trading session, DaVita HealthCare (DVA) closed at $164.22, indicating a -0.59% shift from the previous trading day.
DaVita Accelerates Commitment to Community Health with Nationwide Tour
Kidney care leader provides free health screenings and resources to create awareness around kidney disease and open discussion around health care access DENVER , Sept. 17, 2024 /PRNewswire/ -- DaVita (NYSE: DVA), a leading provider of kidney care services, today...
Source: https://incomestatements.info
Category: Stock Reports